This week on Pharma Research VIDEO Report: 1) Ernst & Young’s annual global pharmaceutical industry report is chock-full of insights about the critical business relationship between pharmaceutical companies and payers that needs substantial repair. 2) An IMS Institute for Healthcare Informatics shows that the impressive $91 billion invested worldwide — annually — in oncology medicines has been significantly slowing. 3) A Mobiquity survey, conduct by Research Now, reveals 55% of health & fitness app users plan to buy wearable devices to track and improve their health because they believe they are physically benefitting.
Early ACA Rx trends; IMS Health IPO; Med Payments Getting Easier (PRVR–4/14/2014)
This week on Pharma Research VIDEO Report: 1) Express Scripts details prescription order trends with ACA enrollees in January and February. 2) A Milliman study for CVS Caremark suggests moving specialty drug payment responsibility from medical to pharmacy benefits. 3) IMS Health’s IPO makes common stock available at $20.00 per share. 4) The percentage of people under 65 having difficulty paying their medical bills dropped between 2011 and 2013 due to improved economic conditions. 5) Vermont is moving to implement single player health care and needs to raise $2 billion per year to get it started.
Biotech’s 1st Chief Patient Officer; ACA boosts Medicaid Rx spend (PRVR–4/7 to 4/11/2014)
This week on Pharma Research VIDEO Report: 1) Pharmaceutical companies have cut back on what they pay physicians to speak on their behalf, but the real attention getter will be the searchable database patients will be able to access with 2013 data on pharmacy spending of $10 or more with each U.S. doctor. 2) Sanofi breaks new industry ground by appointing the first Chief Patient Officer. 3) Charlotte Sibley returns to recommend three steps that pharmaceutical companies can take with their research departments to implement Big Data opportunities. 4) With the ACA’s 2014 enrollment period in the past, the first reports of its impact on the pharmaceutical industry are being released.
vitaTrackr: Let’s create data-enabled healthcare; IBM Watson battles cancer (PRVR–3/31/14)
This week on Pharma Research VIDEO Report:
1) Hats off to vitaTrackr, which has decided to take the lead by inviting key elements of the health care industry to join it in a collaboration to create the foundation for data-enabled health care. 2) IBM Watson is being assigned its most challenging task to date: helping to find medical cures for glioblastoma patients. 3) Pharma MR stalwart and proponent Charlotte Sibley speaks with Bob Lederer about how and why many pharmacos are missing the boat with Big Data. 4) The Ogilvy Awards handed out at the ARF ReThink Conference awarded 6 different health care-related organizations in a New York ceremony on March 25.
Clinical caution with social media; Health problems versus coverage; MD new Rx adoption (PMRV–3/17/2014)
News on this week’s Pharma Research VIDEO Report:
1) The Tufts Center for the Study of Drug Development comments on the pharmaceutical industry’s cautious use of social media, explaining how it could be accelerated.
2) Prosper Insights & Analytics released its “Healthcare Coverage Vital Signs Matrix,” which studies the links between health problems of individuals and their actual healthcare coverage.
3) M/A/R/C Research EVP Randy Wahl discusses research’s tendency to overstate adoption of new drugs and what is being done about it.
4) The Center for Medicare & Medicare Services withdrew its proposal to revise Medicare Part D following protests in Washington by insurers, pharmacies, pharmacies, health providers and patients.
RFL Communications, Inc. 